StockData
Innospec Inc. logo

Innospec Inc. (IOSP) stock

IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3015% below fair value
$78.01−1.16 (-1.47%)

Close on Nov 17, 2026Market cap $1.92BP/E –Yield 2.19%

Innospec r&d expenses

Research and development expenses are spending on new products and technology.

Innospec's R&D Expenses for the twelve months ending Jun 30, 2026 was $52.10M, down 4.9% year over year. For fiscal 2025 it was $51.00M, down 9.7% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $56.50M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$51.00M-9.7%
FY2024Dec 31, 2024$56.50M+15.3%
FY2023Dec 31, 2023$49.00M+26.6%
FY2022Dec 31, 2022$38.70M+3.5%
FY2021Dec 31, 2021$37.40M+21.0%
FY2020Dec 31, 2020$30.90M-12.7%
FY2019Dec 31, 2019$35.40M+6.0%
FY2018Dec 31, 2018$33.40M+6.4%
FY2017Dec 31, 2017$31.40M+23.6%
FY2016Dec 31, 2016$25.40M+0.4%
FY2015Dec 31, 2015$25.30M+14.0%
FY2014Dec 31, 2014$22.20M+4.7%
FY2013Dec 31, 2013$21.20M+8.2%
FY2012Dec 31, 2012$19.60M+7.1%
FY2011Dec 31, 2011$18.30M+4.0%
FY2010Dec 31, 2010$17.60M+7.3%
FY2009Dec 31, 2009$16.40M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$14.20M+4.4%
Q1 FY2026Mar 31, 2026$13.20M+3.9%
Q4 FY2025Dec 31, 2025$11.00M-26.2%
Q3 FY2025Sep 30, 2025$13.70M+0.7%
Q2 FY2025Jun 30, 2025$13.60M-2.9%
Q1 FY2025Mar 31, 2025$12.70M-9.3%
Q4 FY2024Dec 31, 2024$14.90M-8.0%
Q3 FY2024Sep 30, 2024$13.60M+17.2%
Q2 FY2024Jun 30, 2024$14.00M+32.1%
Q1 FY2024Mar 31, 2024$14.00M+32.1%
Q4 FY2023Dec 31, 2023$16.20M+92.9%
Q3 FY2023Sep 30, 2023$11.60M+14.9%
Q2 FY2023Jun 30, 2023$10.60M+5.0%
Q1 FY2023Mar 31, 2023$10.60M+5.0%
Q4 FY2022Dec 31, 2022$8.40M-11.6%
Q3 FY2022Sep 30, 2022$10.10M-1.9%
Q2 FY2022Jun 30, 2022$10.10M+17.4%
Q1 FY2022Mar 31, 2022$10.10M+12.2%
Q4 FY2021Dec 31, 2021$9.50M+46.2%
Q3 FY2021Sep 30, 2021$10.30M+33.8%
Q2 FY2021Jun 30, 2021$8.60M+6.2%
Q1 FY2021Mar 31, 2021$9.00M+4.7%
Q4 FY2020Dec 31, 2020$6.50M-22.6%
Q3 FY2020Sep 30, 2020$7.70M-20.6%
Q2 FY2020Jun 30, 2020$8.10M-1.2%
Q1 FY2020Mar 31, 2020$8.60M-5.5%
Q4 FY2019Dec 31, 2019$8.40M+1.2%
Q3 FY2019Sep 30, 2019$9.70M+19.8%
Q2 FY2019Jun 30, 2019$8.20M-5.7%
Q1 FY2019Mar 31, 2019$9.10M+9.6%
Q4 FY2018Dec 31, 2018$8.30M+9.2%
Q3 FY2018Sep 30, 2018$8.10M+2.5%
Q2 FY2018Jun 30, 2018$8.70M+2.4%
Q1 FY2018Mar 31, 2018$8.30M+12.2%
Q4 FY2017Dec 31, 2017$7.60M+31.0%
Q3 FY2017Sep 30, 2017$7.90M+21.5%
Q2 FY2017Jun 30, 2017$8.50M–
Q1 FY2017Mar 31, 2017$7.40M–
Q4 FY2016Dec 31, 2016$5.80M–
Q3 FY2016Sep 30, 2016$6.50M–

More Innospec figures

See a number that looks wrong?